Homocysteine is toxic for dopaminergic neurons in primary mesencephalic culture

NeuroReport

Volumn 18, Issue 13, 2007, Pages 1319-1322

  Imamura, Keiko ^a   Takeshima, Takao ^a   Nakaso, Kazuhiro ^a   Nakashima, Kenji ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

1 methyl 4 phenylpyridinium; Dopamine; Tyrosine hydroxylase

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; HOMOCYSTEINE; MICROTUBULE PROTEIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; HYPERHOMOCYSTEINEMIA; MESENCEPHALON; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; ANTIPSYCHOTIC AGENTS; CELLS, CULTURED; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EMBRYO; FEMALE; HOMOCYSTEINE; MESENCEPHALON; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS; NEUROTOXINS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RESERPINE; TYROSINE 3-MONOOXYGENASE;

EID: 34548319411     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3282aaa0b4     Document Type: Article

References (23)

1. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49:31-62.
2. Kim NK, Choi BO, Jung WS, Choi YJ, Choi KG. Hyperhomocysteinemia as an independent risk factor for silent brain infarction. Neurology 2003; 61:1595-1599.
3. Morris MS. Homocysteine and Alzheimer's disease. Lancet Neurol 2003; 2:425-428.
4. Lazarewicz JW, Ziembowicz A, Matyja E, Stafiej A, Zieminska E. Homocysteine-evoked 45Ca release in the rabbit hippocampus is mediated by both NMDA and group I metabotropic glutamate receptors: in vivo microdialysis study. Neurochem Res 2003; 28:259-269.
5. Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, Rayudu PV, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 1997; 94:5923-5928.
6. Kreis W, Goodenow M. Methionine requirement and replacement by homocysteine in tissue cultures of selected rodent and human malignant and normal cells. Cancer Res 1978; 38:2259-2262.
7. Hultberg B, Andersson A, Isaksson A. Metabolism of homocysteine, its relation to the other cellular thiols and its mechanism of cell damage in a cell culture line (human histiocytic cell line U-937). Biochim Biophys Acta 1995; 1269:6-12.
8. Finkelstein JD, Martin JJ. Homocysteine. Int J Biochem Cell Biol 2000; 32:385-389.
9. Giles WH, Kittner SJ, Ou CY, Croft JB, Brown V, Buchholz DW, et al. Thermolabile methylenetetrahydrofolate reductase polymorphism (C677T) and total homocysteine concentration among African-American and white women. Ethn Dis 1998; 8:149-157.
10. Miller JW, Selhub J, Nadeau MR, Thomas CA, Feldman RG, Wolf PA. Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status. Neurology 2003; 60:1125-1129.
11. Yasui K, Nakaso K, Kowa H, Takeshima T, Nakashima K. Levodopa-induced hyperhomocysteinaemia in Parkinson's disease. Acta Neurol Scand 2003; 108:66-67.
12. Duan W, Ladenheim B, Cutler RG, Kruman II, Cadet JL, Mattson MP. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J Neurochem 2002; 80:101-110.
13. Lee ES, Chen H, Soliman KF, Charlton CG. Effects of homocysteine on the dopaminergic system and behavior in rodents. Neurotoxicology 2005; 26:361-371.
14. Chandra G, Gangopadhyay PK, Senthil Kumar KS, Mohanakumar KP. Acute intranigral homocysteine administration produces stereotypic behavioral changes and striatal dopamine depletion in Sprague-Dawley rats. Brain Res 2006; 1075:81-92.
15. Takeshima T, Shimoda K, Johnston JM, Commissiong JW. Standardized methods to bioassay neurotrophic factors for dopaminergic neurons. J Neurosci Methods 1996; 67:27-41.
16. Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL. D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci USA 2000; 97:5440-5444.
17. Basma AN, Morris EJ, Nicklas WJ, Geller HM. L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation. J Neurochem 1995; 64:825-832.
18. Varoqui H, Erickson JD. Vesicular neurotransmitter transporters. Potential sites for the regulation of synaptic function. Mol Neurobiol 1997; 15:165-191.
19. Grieve A, Butcher SP, Griffiths R. Synaptosomal plasma membrane transport of excitatory sulphur amino acid transmitter candidates: kinetic characterisation and analysis of carrier specificity. J Neurosci Res 1992; 32:60-68.
20. Langston JW. The etiology of Parkinson's disease with emphasis on the MPTP story. Neurology 1996; 47(6 Suppl 3):S153-S160.
21. +)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide. Biochem J 2003; 371:151-164.
22. Chern CL, Huang RF, Chen YH, Cheng JT, Liu TZ. Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells. Biomed Pharmacother 2001; 55:434-442.
23. Tyagi N, Ovechkin AV, Lominadze D, Moshal KS, Tyagi SC. Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia. J Cell Biochem 2006; 98:1150-1162.